Open access
A Gut-Specific Bispecific Combining MAdCAM-1 Blockade and IL-22 Signaling to Halt T-Cell Inflammation and Promote Mucosal Restoration
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.